StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · ALMR·Healthcare

Alamar Biosciences, Inc. Stock Analysis & AI Score

Alamar Biosciences, Inc. (ALMR) has an ST Score of 67.3 (B), driven by its Momentum (A+) and held back by its Forecast (C+). Analysts rate it Buy with a $33.50 price target (+0.9% upside).

Market Closed
$33.20
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
67
ST Score
67.3/100B

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

ALMR
67.3out of 100
Grade B

Alamar Biosciences, Inc. (ALMR) has an ST Score of 67.3 (B), driven by its Momentum (A+) and held back by its Forecast (C+). Analysts rate it Buy with a $33.50 price target (+0.9% upside).

Strongest
MomentumA+
Weakest
ForecastC+
All factor grades
  • MomentumA+
  • SentimentA+
  • ProfitabilityB
  • Financial StrengthB
  • ValuationB-
  • GrowthC+
  • ForecastC+
Score methodology
Press Releases

Contact

ALMR stock: frequently asked questions

What is ALMR's ST Score?

Alamar Biosciences, Inc. (ALMR) has an ST Score of 67.3 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is ALMR a buy, hold, or sell?

Analysts rate ALMR a Buy, with a price target of $33.50 (+0.9% vs the current price). Our ST Score grades it B (67.3/100). The ST Score is a data-driven signal, not a recommendation.

What are ALMR's factor grades?

Valuation B-, Profitability B, Financial Strength B, Momentum A+, Growth C+, Forecast C+, Sentiment A+.

What is ALMR's valuation grade?

Alamar Biosciences, Inc. (ALMR) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is ALMR's growth grade?

Alamar Biosciences, Inc. (ALMR) earns a growth grade of C+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is ALMR's profitability grade?

Alamar Biosciences, Inc. (ALMR) earns a profitability grade of B, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is ALMR's financial strength grade?

Alamar Biosciences, Inc. (ALMR) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for ALMR?

The average analyst price target for Alamar Biosciences, Inc. (ALMR) is $33.50 from 2 analysts, which is +0.9% versus the recent price of $33.20.